Clinical Trial Update: Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imetelstat in combination with paclitaxel, with or without bevacizumab, in locally recurrent or metastatic breast cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Locally Recurrent Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Imetelstat (imetelstat)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Geron Corporation | Conditions: Locally Recurrent or Metastatic Breast Cancer | Phase 2 | Status: COMPLETED